The Enterprise Value as of November 2024 (TTM) for XOMA Corporation (XOMA) is 339.22M

According to XOMA Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 339.22M. This represents a change of 58.42% compared to the average of 214.12M of the last 4 quarters.

XOMA Corporation (XOMA) Historical Enterprise Value (quarterly & annually)

How has XOMA Enterprise Value performed in the past?

The mean historical Enterprise Value of XOMA Corporation over the last ten years is 195.12M. The current 339.22M Enterprise Value has changed 17.28% with respect to the historical average. Over the past ten years (40 quarters), XOMA's Enterprise Value was at its highest in in the June 2015 quarter at 453.10M. The Enterprise Value was at its lowest in in the December 2016 quarter at 42.95M.

XOMA Corporation (XOMA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of XOMA Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

XOMA Corporation (XOMA) Average Enterprise Value

How has XOMA Enterprise Value performed in the past?

The current Enterprise Value of XOMA Corporation (XOMA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

XOMA Corporation (XOMA) Enterprise Value vs. Peers

How is XOMA’s Enterprise Value compared to its peers?

XOMA Corporation’s Enterprise Value is greater than Werewolf Therapeutics, Inc. (139.97K), less than Edgewise Therapeutics, Inc. (3.19B), greater than Decibel Therapeutics, Inc. (96.42M), less than Celcuity Inc. (634.84M), less than C4 Therapeutics, Inc. (462.75M), greater than Third Harmonic Bio, Inc. (245.75M), greater than Passage Bio, Inc. (38.72M), greater than Acrivon Therapeutics, Inc. Common Stock (201.35M), greater than Eliem Therapeutics, Inc. (119.64M), greater than TRACON Pharmaceuticals, Inc. (-6133696.00), greater than Rezolute, Inc. (236.08M), greater than Sio Gene Therapies Inc. (-15427292.00), greater than Vincerx Pharma, Inc. (4.98M), less than Stoke Therapeutics, Inc. (501.96M), less than Crinetics Pharmaceuticals, Inc. (4.87B), less than Dyne Therapeutics, Inc. (2.31B), less than Revolution Medicines, Inc. (9.07B), greater than Design Therapeutics, Inc. (258.23M), less than Tango Therapeutics, Inc. (539.13M), greater than Talaris Therapeutics, Inc. (50.00M), greater than Achilles Therapeutics plc (-48532901.00),

Build a custom stock screener for XOMA Corporation (XOMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XOMA Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

XOMA Corporation (XOMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like XOMA Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.